Home/Filings/4/0001062993-23-004044
4//SEC Filing

Brenner Erin K. 4

Accession 0001062993-23-004044

CIK 0001835567other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:14 PM ET

Size

5.4 KB

Accession

0001062993-23-004044

Insider Transaction Report

Form 4
Period: 2023-02-15
Brenner Erin K.
Chief Product Dev. Officer
Transactions
  • Award

    Restricted Stock Units

    2023-02-15+952,380952,380 total
    Class A Common Stock (952,380 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.
  • [F2]The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.

Issuer

Pear Therapeutics, Inc.

CIK 0001835567

Entity typeother

Related Parties

1
  • filerCIK 0001881042

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:14 PM ET
Size
5.4 KB